Journal List > Tuberc Respir Dis > v.70(6) > 1001628

Lee: Effect of Apocynin on Acute Lung Injury in Rats Given Interleukin-1α Intratracheally

Abstract

Background

Based on the assertion that apocynin diminishes acute lung injury (ALI) by inhibition of NADPH oxidase, the effect of apocynin was tested in interleukin-1α (IL-1)-induced ALI in rats.

Methods

IL-1 was insufflated into the trachea of Sprague-Dawley rats to induce ALI, and apocynin (8 mg/kg) was given intravenously for inhibition of NADPH oxidase. In addition, we determined whether apocynin inhibited generation of superoxide anions from isolated human neutrophils. Five hours after IL-1 instillation, lung injury parameters, expression of cytosolic phospholipase A2 (cPLA2) by cells from bronchoalveolar lavage (BAL), an index of oxidative stress in lung tissues (γ-glutamyltranspeptidase, activity), and ultrastructure of alveolar type II (AT II) cells were evaluated.

Results

Apocynin decreased the generation of free radicals from phorbol myristate (PMA)-activated neutrophils in vitro, but did not ameliorate ALI. IL-1 induced enhancement of the expression of cPLA2 on neutrophils was not altered by apocynin.

Conclusion

Apocynin induced suppression of the generation of superoxide anions from neutrophils by inhibition of NADPH oxidase does not attenuate IL-1-induced ALI in rats.

Introduction

The pathogenesis of acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) is a coordinated series of inflammatory process and proinflammatory cytokines play a key role to provoke acute inflammatory pulmonary edema1. Among the proinflammatory cytokines which are responsible for the eliciting acute inflammatory lung injury, interleukin-1 (IL-1) has long been recognized as a causative cytokine to induce ALI by neutrophilic oxidative stress and activation of phospholipase A2 (PLA2)2.
In IL-1-induced ALI in experimental animals, neutrophilic accumulation in the lung and subsequent oxidative stress-induced lung injury are prominent and the activated PLA2 by IL-1 generates proinflammatory eicosanoids3. The oxidative stress in IL-1-induced ALI has been considered as the results of the activation of NADPH oxidase in neutrophils by proinflammatory lipid molecules produced by activated PLA24. As was pointed out, PLA2 is an effector of proinflammatory cytokines and the role of PLA2 in the pathogenesis of ALI is evident in conjuction with neutrophilic respiratory burst5.
Because NADPH oxidase is essential for the initiation of free radical formation from neutrophils6, investigators have tried to ameliorate lung injury by inhibition of NADPH oxidase with apocynin with some successful results. They insisted that apocynin (4-hydroxy-3-methoxyacetophenone) was effective to decrease lung injury through the suppression of oxidative stress by phagocytes7,8. But opposite result was reported also9 and the effect of apocynin on ALI is still controversial.
For the activation of NADPH oxidase in phagocytes, the activation of PLA2, especially cytosolic PLA2 appears indispensable10 and one of the metabolite of cPLA2 activation, arachidonic acid is not only involved in the activation of NADPH oxidase but also takes part in the inflammatory process irrespective of the activation of NADPH oxidase in phagocytes11. For instance, cPLA2-α regulates inflammation by production of platelet-activating factor without NADPH oxidase activity12.
Since IL-1-induced ALI comprises all of the conditions of oxidative stress by NADPH oxidase and activation of PLA2, to test the effect of apocynin on IL-1-induced ALI seems to be worthwhile.
Therefore, in the present study, the effect of apocynin was probed in IL-1-induced ALI associated with oxidative stress and the activation of cPLA2 in neutrophils.

Materials and Methods

1. Animals and reagents

Male Sprague-Dawley rats (300 to 350 g, pathogen free) were purchased from Sasco Korea. Not otherwise mentioned, all experimental reagents were purchased from Sigma-Aldrich Company. (St. Louis, MO, USA). Recombinant human interleukin-1α (IL-1, endotoxin level 1< EU/mg) was purchased from R&D systems (Mineapolis, MN, USA), frozen in aliquots, and thawed daily before use. 125I-labeled bovine serum albumin (125I-BSA) was obtained from ICN Radiochemicals (Irvine, CA, USA). Goat anti-human cPLA2 polyclonal antibody was purchased from Santa Cruz Biochem (Santa Cruz, CA, USA).

2. Induction of ALI

Animals were fed ad libitum till 24 hours before experiments. ALI was induced as described previously13. Fifty nanogram of IL-1 was dissolved in 1.0 mL of normal saline and this solution was insufflated into the trachea. The NADPH oxidase inhibitor apocynin (8 mg/kg)4 was administered through the femoral vein just after instillation of IL-1. To sham treated rats, 1.0 mL of normal saline was instilled into the trachea.

3. Bronchoalveolar lavage (BAL) and count of neutrophils

Lung lavage was performed by cannulating the trachea and instilling 8.0 mL of normal saline with a syringe. Approximately 6.0 mL of lavage fluid was recovered from each rat. After the recovered lung lavage was centrifuged (1,000 g; 10 minutes), the supernatant was collected and stored at -20℃ for measurement of protein. The sedimented cellular pellet was resuspended in 1.0 mL of distilled water and 1.0 mL of Hank's balanced salt solution (HBSS) for 2 seconds to lyse erythrocytes, then centrifuged again. The supernatant was discarded and the pellet was resuspended in 1.0 mL of normal saline. Using 200µL of suspended solution, cytospin slides were prepared and Wright stained for differential cell count. Total leukocyte counts were performed with a hemocytometer and the fraction of neutrophils was calculated by determining the percentage of neutrophils.

4. Measurement of BAL protein

BAL protein was determined as described previously by Brown et al14. using supernatant of BAL. Bicinchoninic acid was used as chromogenic substrate.

5. Measurement of lung leak:

Four and half hours after IL-1 instillation, 125I-BSA (1.0µCi) was injected through jugular vein. One mL of blood was withdrawn 30 minutes later from the right atrium and then assayed for radioactivity. Subsequently, lungs were perfused blood free with normal saline and removed. Lung leak index was calculated as the ratio of radioactivity in the right lung to radioactivity in 1.0 mL of blood.

6. Lung myeloperoxidase (MPO) assay

To assess the accumulation of neutrophils in the lung, lung MPO was determined as previously described by Goldblum et al15. with modification. MPO activity was measured using o-dianisidine as the chromogenic substrate and H2O2 to initiate the reaction. Light absorbance at 460 nM was proportional to MPO activity.

7. Determination of NADPH oxidase assay

Cytochrome-C reduction assay; Neutrophils were isolated as described previously according to Botha et al16. Briefly, the mixture of 15 mL of pentaspan and 0.1 mL of heparin (1,000 units) were mixed with 30 mL of fresh human blood before standing for 40 minutes at room temperature. Then the plasma layered on 74%, 55% isotonic percoll gradient after separation from erythrocytes, centrifuged (1,500 rpm; 20 minutes) and neutrophils were collected from the interface of 74, 55% of percoll gradients. With isolated neutrophils, NADPH oxidase activity was determined by the method of cytochrome-c reduction assay described previously17. Collected suspension of neutrophils was hypotonic lysed for removal of erythrocytes and washed twice with PBS. For cytochrome-c assay, except control samples, phorbol myristate acetate (PMA, 2.5µg/mL) and apocynin (100µM) were added to the neutrophil suspension (2×107 cells) before incubating for 15 minutes at 37℃. Light absorbance at 550 nM was proportional to the reduction of cytochrome-c by free radicals.

8. Determination of γ-glutamyltranspeptidase (GGT) activity in the lung tissue

As an index of oxidative stress in lung tissues, GGT activity was measured as previously described by Meister et al.18 Briefly, 0.2 mL of L-γ-p-nitroanilide (1 mM), 0.2 mL of glycylglycine (20 mM) and 0.4 mL of Tris-Hcl buffer, and 0.2 mL of lung homogenate were added in the tube and incubated at 37℃ for 30 minutes in shaking water bath. The reaction was stopped by adding 0.1 mL of 50 mM of serine borate solution. The release of p-nitroaniline was recorded as the change of absorbance at 410 nM. The specific activity was expressed as µ moles of p-nitraniline released per minute per mg of protein.

9. Histological preparations for examination of alveolar type II cell

Small blocks (1 mm3) of lung tissue were rapidly fixed in the cold 2.5% glutaraldehyde and the small tissue blocks were degassed by the applying of the pressurized air (20 cm H2O) into the sealed vial. The prefixed tissues were rinsed with PBS (pH 7.4) and post fixed 1% OsO4. After dehydrated with graded ethanol-propylene, the tissues were embedded in epoxy-resin. The embedded tissues were polymerized at 37℃ for 12 hours and at 60℃ for 24 hours before ultra thin section. The sections were stained with uranyl acetate and lead citrate before electron microscopy (H600, Hitachi, Japan).

10. Immunohistochemistry of cPLA2 in BAL cells

Cytospinned cells were subjected to staining for fluorescence for cPLA2 in BAL cells. Goat-anti-human-cPLA2 polyclonal antibody (C-20, Santa Cruz, CA, USA) was used as first antibody. The antibody complex was visualized by staining with propidium iodide.

11. Statistical analyses

Data were analyzed using a one-way analysis of variance with a Student-Newman-Keuls multiple comparisons test. A p-value of <0.05 was considered statistically significant.

Results

1. Effect of apocynin on the accumulation and the migration of neutrophils

As was shown in Table 1, numbers of neutrophils in BAL were higher in IL-1 treated rats than those of sham treated rats (p<0.001). Apocynin did not decrease the numbers of neutrophils in BAL of IL-1 treated rats. Apocynin did not affect the accumulation of neutrophils by IL-1 either. The MPO activity of the lung was much higher (p<0.001) in IL-1 treated rats compared with that of sham treated rats. But it was not decreased by apocynin.

2. Effect of apocynin on lung leak

Assay of BAL protein and measurement of lung leak index (LLI) revealed the increased protein leak in IL-1 treated rats (p<0.001) compared with those of sham treated rats. Apocynin was not effective to suppress the lung leak in IL-1 treated rats (Table 2).

3. Effect of apocynin on neutrophilic generation of superoxide anion

In phorbol myristate acetate (PMA)-stimulated neutrophils, the amount of reduced cytochrome-c was very much more than that of non-stimulated neutrophils (p<0.001). Apocynin had decreased the generation of superoxide anion from PMA-stimulated neutrophils (p<0.001) (Table 3).

4. Effect of apocynin on the activity of GGT

As an index of oxidative stress, GGT activity was higher in lung tissues of rats given IL-1 than that of sham treated rats (p<0.001). Apocynin was not effective to suppress the increased GGT activity by IL-1 (Table 4).

5. Ultrastructural changes of alveolar type II cell

In normal alveolar type II cell, lamellar bodies are well preserved (Figure 1A). By contrast, IL-1 elicited typical morphological changes of oxidative stress in alveolar type II cell such as vacuolization, enlargement of lamellar bodies and disruption of basement membrane (Figure 1B). These pathological changes were not altered by apocynin (Figure 1C).

6. Immunohistochemistry of cPLA2 in BAL cells

The BAL cells from the rat given IL-1 showed enhanced expression of cPLA2 in neutrophilic cytoplasms compared with the expression in the cellular cytoplasms of sham treated rats. Apocynin did not alter the increased expression of cPLA2 by IL-1 (Figure 2).

Discussion

IL-1 has been known to be involved in the pathogenesis of ALI by causing neutrophilic oxidative stress19. As an initiator of neutrophilic oxidative stress in cytokine-induced ALI, the significance of NADPH oxidase has long been confirmed20.
In the present study, the inhibition of NADPH oxidase has been tested whether it is effective to reduce lung injury by suppressing oxidative stress in IL-1-induced ALI. Many reports21,22 insisted the beneficial effects of the inhibition of NADPH oxidase by apocynin in various experimental conditions. That is, the inhibition of NADPH oxidase, especially under the condition of neutrophilic accumulation and production of hydrogen peroxide, apocynin was effective to ameliorate the lung injury23.
But in the present study, apocynin did not attenuate ALI induced by IL-1. As was demonstrated in results, IL-1 increased the accumulation of neutrophils in the lung and caused alveolar flooding by the inflammatory process. IL-1 had increased the number of BAL neutrophils and the lung MPO activity. Lung leak and BAL protein had been increased by IL-1 also reflecting the overt acute inflammatory pulmonary edema occurred. Unlike other reports21,22, apocynin was not protective against ALI by IL-1, demonstrated by ineffectiveness of apocynin in reducing lung MPO activity, BAL neutrophils, BAL protein and lung leak index in IL-1 treated rats.
According to the assertion22, apocynin's effects of decreased free radical production has to be potentiated by the MPO and hydrogen peroxide, but in this experiment, apocynin did not show the inhibitory effects on neutrophilic migration and lung leak along with the decreased free radical generation.
Although the inhibition of NADPH oxidase in isolated neutrophils by apocynin decreased the generation of free radicals significantly, the oxidative stress in the lung was not affected by apocynin, which was manifested by the unaltered GGT activity in lung tissues of IL-1 given rats.
Concomitantly, the morphological findings also revealed the ineffectual property of apocynin in diminishing oxidative stress. Alveolar type II cells showed the characteristic changes of oxidative stress24 such as vacuolization and hypertrophy of lamellar bodies in the cytoplasm in IL-1 treated rats. Comparing these changes with the morphology in apocynin treated rats, vacuolization and characteristics of oxidative stress remained.
Clearly, these results reveals that apocynin was not effective to reduce oxidative stress in the lungs of rats given IL-1.
Considering the reports25,26 insisting the protective effects of apocynin on ALI, especially induced by ischemia-reperfusion27, the present data are bewildering and difficult to interpret. But considering the experimental conditions or model for the induction of ALI, there is possibility of other contributing factors causing ALI other than neutrophilic oxidative stress in IL-1-induced ALI in rats. Undoubtedly, IL-1 effected neutrophilic accumulation and oxidative stress as was demonstrated in results. However, the role of neutrophilic oxidative stress might be limited in full blown inflammatory reaction of IL-1-induced ALI.
One of the complexities of pathogenesis in IL-1-induced acute lung injury is derived from the activation of PLA2 by IL-128. By the activation of PLA2, diverse proinflammatory lipid molecules are released from lung tissues and phagocytes. Among these lipid molecules, several lipids are responsible for the activation of NADPH oxidase, but at the same time, some lipid molecules have inflammatory functions irrespective of the function of NADPH oxidase29.
The immunohistochemistry of BAL cells indicated the increased expression of cPLA2 in BAL neutrophils by IL-1. In the BAL cells, cPLA2s were expressed exclusively in the cytoplasms of neutrophils. The increased expression of cPLA2s by IL-1 was not altered by apocynin, and from which it is possible to deduce that the unaffected activation of cPLA2 in neutrophils led to the inflammatory reaction in the lungs of rats given IL-1. According to Brechard and Tschirhart, NADPH oxidase is not inhibited as long as cPLA2 is activated and results in this study are in agreement with this literature30. Another possibility is that free radicals were generated by the activation of cPLA2 without NADPH oxidase. Kim et al. reported that free radicals could be generated in non-phagocytic cells without NADPH oxidase by activated cPLA231.
In addition, some authors insisted that in non-phagocytic cells, apocynin stimulated free radical production instead9. The released arachidonic acid by cPLA2 initiates the activation of NADPH oxidase but at the same time, produces free radicals without NADPH oxidase32.
Collectively, the results from present study suggest that even though apocynin is effective to decrease neutrophilic respiratory burst in vitro, apocynin does not ameliorate IL-1-induced ALI in rats.

Figures and Tables

Figure 1
Effect of apocynin on ultrastructure of alveolar type II cell in the lung of rat given IL-1 intratracheally. In the alveolar type II cell of sham treated rat, well-preserved lamellar bodies were visible (A, original magnification, ×6,000). By contrast, alveolar type II cell in IL-1 given rat showed large vacuoles which had been lamellar bodies (*). This finding is a pathognomonic sign of pulmonary oxidative stress (B, original magnification, ×10,000). Apocynin did not alter the ultrastructural changes by the IL-1-induced oxidative stress (C, original magnification, ×10,000). LB: lamellar body; M: mitochondria; AT-II: alveolar type II cell; Np: neutrophil.
trd-70-482-g001
Figure 2
Effect of apocynin on the expression of cPLA2 in the cells in BAL. The cells in BAL from sham treated rats did not show the expression of cPLA2, and the majority of the cells were monocytes (A, propidium iodide, original magnification, ×200). By contrast, in BAL of IL-1 treated rats, almost all of the cells were neutrophils and the expression of cPLA2 was conspicuous in their cytoplasm (B, propidium iodide, original magnification, ×100). On the other hand, apocynin did not suppress the expression of cPLA2 of the cells in BAL of IL-1 treated rats (C, propidium iodide, original magnification, ×200).
trd-70-482-g002
Table 1
Effect of apocynin on neutrophilic infiltration and migration in the lungs of rats given IL-1 intratracheally
trd-70-482-i001

Values are presented as mean±SD.

*p<0.001; Sham vs. IL-1, p=0.993; IL-1 vs. IL-1+apo, p<0.001; Sham vs. IL-1, §p=0.969; IL-1 vs. IL-1+apo.

IL-1: interleukin-1; apo: apocynin; BAL: bronchoalveolar lavage; PMN: polymorphonuclear neutrophil; MPO: myeloperoxidase; SD: standard deviation.

Table 2
Effect of apocynin on acute lung leak in IL-1 given rats
trd-70-482-i002

Values are presented as mean±SD.

*p<0.001; Sham vs. IL-1, p=0.778; IL-1 vs. IL-1+apo, p<0.001; Sham vs. IL-1, §p=0.710; IL-1 vs. IL-1+apo.

LLI: lung leak index; BAL: bronchoalveolar lavage; L-1: interleukin-1α; apo: apocynin; SD: standard deviation.

Table 3
Effect of apocynin on generation of superoxide anion from PMA-activated neutrophils
trd-70-482-i003

Values are presented as mean±SD.

*p<0.001; Control vs. PMA, p<0.001; PMA vs. PMA+apo.

PMA: phorbol myristate acetate; apo: apocynin; PMN: polymorphonuclear neutrophil; SD: standard deviation.

Table 4
Effect of apocynin on the GGT activity in the lung of IL-1 given rats
trd-70-482-i004

Values are presented as mean±SD. 1 unit of GGT: 1µmoL production of p-nitroaniline for one min, per mg of protein.

*p<0.001; Sham vs. IL-1, p=0.515; IL-1 vs. IL-1+apo.

GGT: γ-glutamyl transpeptidase; IL-1: interleukin-1α; Apo: apocynin; SD: standard deviation.

References

1. Downey GP, Granton JT. Mechanisms of acute lung injury. Curr Opin Pulm Med. 1997. 3:234–241.
2. Newton R, Kuitert LM, Slater DM, Adcock IM, Barnes PJ. Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. Life Sci. 1997. 60:67–78.
3. Pruzanski W, Vadas P. Phospholipase A2--a mediator between proximal and distal effectors of inflammation. Immunol Today. 1991. 12:143–146.
4. Kitsiouli E, Nakos G, Lekka ME. Phospholipase A2 subclasses in acute respiratory distress syndrome. Biochim Biophys Acta. 2009. 1792:941–953.
5. Sun K, Qu X, Gao L, Myatt L. Dexamethasone fails to inhibit the induction of cytosolic phospholipase A(2) expression by interleukin-1beta in cultured primary human amnion fibroblasts. Placenta. 2006. 27:164–170.
6. Dana R, Malech HL, Levy R. The requirement for phospholipase A2 for activation of the assembled NADPH oxidase in human neutrophils. Biochem J. 1994. 297:217–223.
7. Impellizzeri D, Esposito E, Mazzon E, Paterniti I, Di Paola R, Bramanti P, et al. Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation. Biochem Pharmacol. 2011. 81:636–648.
8. Yang Z, Sharma AK, Marshall M, Kron IL, Laubach VE. NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. Am J Respir Cell Mol Biol. 2009. 40:375–381.
9. Vejrazka M, Mícek R, Stípek S. Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells. Biochim Biophys Acta. 2005. 1722:143–147.
10. Shmelzer Z, Haddad N, Admon E, Pessach I, Leto TL, Eitan-Hazan Z, et al. Unique targeting of cytosolic phospholipase A2 to plasma membranes mediated by the NADPH oxidase in phagocytes. J Cell Biol. 2003. 162:683–692.
11. Wong RK, Pettit AI, Quinn PA, Jennings SC, Davies JE, Ng LL. Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic acid. Circulation. 2003. 108:1858–1864.
12. Rubin BB, Downey GP, Koh A, Degousee N, Ghomashchi F, Nallan L, et al. Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activity. J Biol Chem. 2005. 280:7519–7529.
13. Hybertson BM, Lee YM, Cho HG, Cho OJ, Repine JE. Alveolar type II cell abnormalities and peroxide formation in lungs of rats given IL-1 intratracheally. Inflammation. 2000. 24:289–303.
14. Brown RE, Jarvis KL, Hyland KJ. Protein measurement using bicinchoninic acid: elimination of interfering substances. Anal Biochem. 1989. 180:136–139.
15. Goldblum SE, Wu KM, Jay M. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol. 1985. 59:1978–1985.
16. Botha AJ, Moore FA, Moore EE, Fontes B, Banerjee A, Peterson VM. Postinjury neutrophil priming and activation states: therapeutic challenges. Shock. 1995. 3:157–166.
17. Haslett C, Guthrie LA, Kopaniak MM, Johnston RB Jr, Henson PM. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol. 1985. 119:101–110.
18. Meister A, Tate SS, Griffith OW. Gamma-glutamyl transpeptidase. Methods Enzymol. 1981. 77:237–253.
19. Oberholzer A, Oberholzer C, Moldawer LL. Cytokine signaling--regulation of the immune response in normal and critically ill states. Crit Care Med. 2000. 28:4 Suppl. N3–N12.
20. Paterniti I, Galuppo M, Mazzon E, Impellizzeri D, Esposito E, Bramanti P, et al. Protective effects of apocynin, an inhibitor of NADPH oxidase activity, in splanchnic artery occlusion and reperfusion. J Leukoc Biol. 2010. 88:993–1003.
21. Pearse DB, Wagner EM, Sylvester JT. Edema clearance in isolated sheep lungs. J Appl Physiol. 1993. 74:126–132.
22. Dodd-o JM, Welsh LE, Salazar JD, Walinsky PL, Peck EA, Shake JG, et al. Effect of NADPH oxidase inhibition on cardiopulmonary bypass-induced lung injury. Am J Physiol Heart Circ Physiol. 2004. 287:H927–H936.
23. Simons JM, Hart BA, Ip Vai Ching TR, Van Dijk H, Labadie RP. Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils. Free Radic Biol Med. 1990. 8:251–258.
24. Mårtensson J, Jain A, Stole E, Frayer W, Auld PA, Meister A. Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress. Proc Natl Acad Sci USA. 1991. 88:9360–9364.
25. Stolk J, Rossie W, Dijkman JH. Apocynin improves the efficacy of secretory leukocyte protease inhibitor in experimental emphysema. Am J Respir Crit Care Med. 1994. 150:1628–1631.
26. Wang W, Suzuki Y, Tanigaki T, Rank DR, Raffin TA. Effect of the NADPH oxidase inhibitor apocynin on septic lung injury in guinea pigs. Am J Respir Crit Care Med. 1994. 150:1449–1452.
27. Pearse DB, Dodd JM. Ischemia-reperfusion lung injury is prevented by apocynin, a novel inhibitor of leukocyte NADPH oxidase. Chest. 1999. 116:1 Suppl. 55S–56S.
28. Lee YM, Hybertson BM, Terada LS, Repine AJ, Cho HG, Repine JE. Mepacrine decreases lung leak in rats given interleukin-1 intratracheally. Am J Respir Crit Care Med. 1997. 155:1624–1628.
29. Linkous A, Yazlovitskaya E. Cytosolic phospholipase A2 as a mediator of disease pathogenesis. Cell Microbiol. 2010. 12:1369–1377.
30. Bréchard S, Tschirhart EJ. Regulation of superoxide production in neutrophils: role of calcium influx. J Leukoc Biol. 2008. 84:1223–1237.
31. Kim C, Kim JY, Kim JH. Cytosolic phospholipase A(2), lipoxygenase metabolites, and reactive oxygen species. BMB Rep. 2008. 41:555–559.
32. O'Dowd YM, El-Benna J, Perianin A, Newsholme P. Inhibition of formyl-methionyl-leucyl-phenylalanine-stimulated respiratory burst in human neutrophils by adrenaline: inhibition of Phospholipase A2 activity but not p47phox phosphorylation and translocation. Biochem Pharmacol. 2004. 67:183–190.
TOOLS
Similar articles